Dorman Products (DORM) Misses Q1 EPS by 36c; reaffirms guidance

Dorman Products (NASDAQ: DORM) reported Q1 EPS of $0.56, $0.36 worse than the analyst estimate of $0.92. Revenue for the quarter came in at $466.7 million versus the consensus estimate of $480.89 million.

GUIDANCE:

Dorman Products sees FY2023 EPS of $5.15-$5.35, versus the consensus of $5.20. Dorman Products sees FY2023 revenue of $1.95-2 billion, versus the consensus of $2 billion.

For earnings history and earnings-related data on Dorman Products (DORM) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Limoneira (LMNR) Misses Q2 EPS by 8c, Beats on Revenue
• United Natural Foods (UNFI) Reports In-Line Q3 EPS ; Offers Outlook